THERESA APPIAH AGANA

Dr. THERESA APPIAH AGANA

Kwame Nkrumah University of Science and Technology, Kumasi, Ashanti, Ghana
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
CAChristian Agyare
Christian Agyare
YBYaw Duah Boakye
Yaw Duah Boakye
EBEmelia Oppong Bekoe
Emelia Oppong Bekoe
AHAndreas Hensel
Andreas Hensel
SDSusana Oteng Dapaah
Susana Oteng Dapaah
TATHERESA APPIAH AGANA
THERESA APPIAH AGANA

1 January 2017 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
TATHERESA APPIAH AGANA
THERESA APPIAH AGANA
YBYaw Duah Boakye
Yaw Duah Boakye
CAChristian Agyare
Christian Agyare
The rapid rise of antimicrobial resistance is a worldwide problem. This has necessitated the need to search for new antimicrobial agents. Mushrooms are rich sources of potential antimicrobial agents. This study investigated the antimicrobial properties of methanol extracts of Trametes gibbosa, Trametes elegans, Schizophyllum commune, and Volvariella volvacea. Agar well diffusion, broth microdilution, and time‐kill kinetic assays were used to determine the antimicrobial activity of the extracts against selected test organisms. Preliminary mycochemical screening revealed the presence of tannins, flavonoids, triterpenoids, anthraquinones, and alkaloids in the extracts. Methanol extracts of T. gibbosa, T. elegans, S. commune, and V. volvacea showed mean zone of growth inhibition of 10.00 ± 0.0 to 21.50 ± 0.84, 10.00 ± 0.0 to 22.00 ± 1.10, 9.00 ± 0.63 to 21.83 ± 1.17, and 12.00 ± 0.0 to 21.17 ± 1.00 mm, respectively. The minimum inhibitory concentration of methanol extracts of T. gibbosa, T. elegans, S. commune, and V. volvacea ranged from 4.0 to 20, 6.0 to 30.0, 8.0 to 10.0, and 6.0 to 20.0 mg/mL, respectively. Time‐kill kinetics studies showed that the extracts possess bacteriostatic action. Methanol extracts of T. gibbosa, T. elegans, S. commune, and V. volvacea exhibited antimicrobial activity and may contain bioactive compounds which may serve as potential antibacterial and antifungal agents.

23 May 2022 in Advances in Pharmacological and Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
AAAkosua Dufie Ankomah
Akosua Dufie Ankomah
YBYaw Duah Boakye
Yaw Duah Boakye
TATHERESA APPIAH AGANA
THERESA APPIAH AGANA
VBVivian Etsiapa Boamah
Vivian Etsiapa Boamah
POPaul Poku Sampene Ossei
Paul Poku Sampene Ossei
CAChristian Agyare
Christian Agyare
Cnestisferruginea is a tropical plant, which is traditionally used in the treatment and management of various conditions including skin infections and wounds. The aim of this study was to investigate the dermal toxicity and wound healing potential of C. ferruginea. Ten millimeter full-thickness mucosal wounds were created on the dorsal midportion of the Sprague Dawley rats. Wounds were treated with 10, 5, and 2.5% w/w aqueous creams, prepared from the methanol extract of the root bark of C. ferruginea (CFM). The wound tissues were harvested on day 21 for histology studies. Compared with the untreated group, 10, 5, and 2.5% w/w CFM-treated wounds significantly reduced the wound size over the study period ( ). Tissue histology revealed a healed wound with well-regenerated collagen and skin appendages with no pus cells. A skin irritation test was conducted on CFM, as well as the dermal toxicity of CFM was determined in the repeated dose and acute dermal toxicity bioassays. These tests revealed that CFM showed no toxic effect on the skin and showed that CFM was not a skin irritant. C. ferruginea exhibited wound healing activity, which gives credence to its folkloric use.

1 November 2021 in Scientific African
Verified
Journal Article
Open access
PAPhilip Asumang
Philip Asumang
YBYaw Duah Boakye
Yaw Duah Boakye
TATHERESA APPIAH AGANA
THERESA APPIAH AGANA
JYJibira Yakubu
Jibira Yakubu
PEPhilomena Entsie
Philomena Entsie
CAChristian Agyare
Christian Agyare

1 June 2021 in Veterinary Parasitology
Verified
Journal Article
Closed access
AOAhmed Wahab Obeng
Ahmed Wahab Obeng
YBYaw Duah Boakye
Yaw Duah Boakye
TATHERESA APPIAH AGANA
THERESA APPIAH AGANA
GDGeorgina Isabella Djameh
Georgina Isabella Djameh
DBDaniel Boamah
Daniel Boamah
FAFrancis Adu
Francis Adu

23 April 2020 in Current Bioactive Compounds
Verified
Journal Article
Closed access
PDF file
TATheresa Appiah
Theresa Appiah
TATHERESA APPIAH AGANA
THERESA APPIAH AGANA
YLYinggang Luo
Yinggang Luo
VBVivian Etsiapa Boamah
Vivian Etsiapa Boamah
YBYaw D. Boakye
Yaw D. Boakye
Background: The development of resistance by pathogenic microorganisms has renewed the worldwide search for novel antimicrobial agents. Mushrooms are of recent interest because a wide variety of biologically active compounds have been isolated from them. This study isolated antimicrobial compound from two wood decaying mushrooms, Trametes gibbosa and Trametes elegans, and determined the resistance modifying activities of the isolated compound. Methods: Bioactivity guided isolation of active principles from the methanol extract of T. gibbosa and T. elegans was performed using column and preparative high-performance liquid chromatography. The structures of isolated compounds were elucidated using nuclear magnetic resonance spectroscopy. Broth micro-dilution assay was used to determine the antimicrobial and resistance modifying activities of the isolated compounds against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Salmonella typhi, Streptococcus pyogenes, Staphylococcus aureus, Enterococcus faecalis, Bacillus subtilis, Candida albicans, Aspergillus niger, Aspergillus flavus and Aspergillus tamarii. Results: Bioactivity guided isolation lead to the isolation of cerevisterol (ergosta-7, 22E-diene-3β5α, 6β- triol) from both T. gibbosa and T. elegans. The isolated cerevisterol inhibited the growth of S. typhi, S. aureus and A. niger with MICs of 25 µg/mL each and 50 μg/mL against E. faecalis. The MBCs of cerevisterol against S. typhi S. aureus, E. faecalis and A. niger were 50, 100, 200 and 100 µg/mL, respectively. The sub-inhibitory concentration (3 µg/mL) of cerevisterol modified the activity of erythromycin, ampicillin, ciprofloxacin, tetracycline and amoxicillin either by potentiating or reducing their activities. Conclusion: Cerevisterol possesses both antimicrobial and resistance modifying activities.